SKU(재고 관리 코드):LMA673Hu
Magnetic Luminex Assay Kit for Dopamine Receptor D2 (DRD2) ,etc.
Magnetic Luminex Assay Kit for Dopamine Receptor D2 (DRD2) ,etc.
Product No.
LMA673Hu
Organism Species
Homo sapiens (Human).
Sample Type
Tissue homogenates, cell lysates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3.5h
Detection Range
0.02-20ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.007 ng/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex
Specificity
This assay has high sensitivity and excellent specificity for detection of Dopamine Receptor D2 (DRD2) ,etc..
No significant cross-reactivity or interference between Dopamine Receptor D2 (DRD2) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Dopamine Receptor D2 (DRD2) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Dopamine Receptor D2 (DRD2) ,etc. in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 78-105 | 87 |
EDTA plasma(n=5) | 95-103 | 101 |
heparin plasma(n=5) | 85-104 | 95 |
sodium citrate plasma(n=5) | 96-104 | 101 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Dopamine Receptor D2 (DRD2) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Dopamine Receptor D2 (DRD2) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Dopamine Receptor D2 (DRD2) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 86-96% | 78-93% | 93-101% | 78-103% |
EDTA plasma(n=5) | 97-104% | 81-90% | 97-104% | 89-99% |
heparin plasma(n=5) | 98-105% | 78-97% | 81-96% | 98-105% |
sodium citrate plasma(n=5) | 93-101% | 84-96% | 81-97% | 94-101% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
96-well plate | 1 | Plate sealer for 96 wells | 4 |
Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
Pre-Mixed Magnetic beads (22#:DRD2) | 1 | Analysis buffer | 1×20mL |
Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
Magazine | Citations |
Front Behav Neurosci | Distinct patterns of outcome valuation and amygdala-prefrontal cortex synaptic remodeling in adolescence and adulthood PubMed: 25999830 |
Behavioural Brain Research | Sex differences, learning flexibility, and striatal dopamine D1 and D2 following adolescent drug exposure in rats Pubmed:27091300 |
South African Journal of Botany | Evaluation of the effect of herbal extracts and their bioactive compounds against motion sickness by regulating neurotransmitter levels in vitro and in vivo |
UCLA Electronic Theses and Dissertations | Benefit, Burdens and Brain Correlates of Heightened Reward Sensitivity in Adolescence |
The GLP-1/GIP dual receptor agonist DA5-CH is superior to Exendin-4 in protecting neurons in the 6-OHDA rat Parkinson Model | |
ВЛИЯНИЕ ХРОНИЧЕСКОГО ВВЕДЕНИЯ НЕЙРОЛЕПТИКОВ НА УРОВНИ НЕЙРОСПЕЦИФИЧЕСКИХ АУТОАНТИТЕЛ В КРОВИ У КРЫС | |
JOURNAL OF FOOD BIOCHEMISTRY | Menthol, a bioactive constituent of Mentha, attenuates motion sickness in mice model: Involvement of dopaminergic system 34245039 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPA673Hu01 | Recombinant Dopamine Receptor D2 (DRD2) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA673Hu02 | Recombinant Dopamine Receptor D2 (DRD2) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA673Hu01 | Polyclonal Antibody to Dopamine Receptor D2 (DRD2) | WB; IHC; ICC; IP. |
MAA673Hu22 | Monoclonal Antibody to Dopamine Receptor D2 (DRD2) | WB; IHC; ICC; IP. |
SEA673Hu | ELISA Kit for Dopamine Receptor D2 (DRD2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA673Hu | Magnetic Luminex Assay Kit for Dopamine Receptor D2 (DRD2) ,etc. | Magnetic Luminex Assay for Antigen Detection. |